Full-Year Guidance -- Net sales projected at $2.9 billion to $2.95 billion, adjusted EBITDA of $340 million to $360 million, ...
At this time, I would like to welcome everyone to Atkore's Second Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Thank you ...
Atkore Inc. (NYSE: ATKR) Q2 2026 Earnings Call Transcript May 5, 2026 Atkore Inc. beats earnings expectations. Reported EPS ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results